瀏覽量: 103
- 產(chǎn)品名稱(chēng): tirzepatide
- 產(chǎn)品貨號(hào): CS1111
- 貨期: 現(xiàn)貨
- 價(jià)格與訂購(gòu): 1500
- 數(shù)量:
- 規(guī)格: 10mg 20mg
- 產(chǎn)品信息
- 如何訂購(gòu)
產(chǎn)品名
tirzepatide
產(chǎn)品描述
Tirzepatide (TZP), a novel dual GIP and GLP-1 receptor agonist (RA).
別名
LY3298176
分子量
4813.45
分子式
C225H348N48O68
CAS No.
2023788-19-2
Peptide Sequence
Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{diacid-gamma-Glu-(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
存儲(chǔ)
Powder: -20°C for 3 years
In solvent: -80°C for 6 months
參考文獻(xiàn)
1. Frias JP, et al. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial. Lancet. 2018 Nov 17;392(10160):2180-2193.
Note
For research use only .
上一篇 IRGD